Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer (Q70469321)
Jump to navigation
Jump to search
scientific article published on 01 February 1993
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer |
scientific article published on 01 February 1993 |
Statements
Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer (English)
N C Munshi
D E Seitz
F Fossella
S M Lippman
1 February 1993
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference